{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:50:08Z","timestamp":1786989008425,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.euroneuro.2015.05.007","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T09:25:58Z","timestamp":1433582758000},"page":"1637-1649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 4h apart Human pharmacology of MDMA after repeated doses taken 4h apart"],"prefix":"10.1016","volume":"25","author":[{"given":"Mag\u00ed","family":"Farr\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angels","family":"Tomillero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"P\u00e9rez-Ma\u00f1\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samanta","family":"Yubero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Papaseit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere-Nolasc","family":"Roset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitona","family":"Pujadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Torrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Cam\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2015.05.007_bib1","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.neuroscience.2008.01.007","article-title":"Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges","volume":"152","author":"Baumann","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00004714-200008000-00010","article-title":"Human pharmacology of 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d): psychomotor performance and subjective effects","volume":"20","author":"Cam\u00ed","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib3","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMra023160","article-title":"Drug addiction","volume":"349","author":"Cam\u00ed","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s002130100727","article-title":"Effects of repeated oral methamphetamine administration in humans","volume":"155","author":"Comer","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"11","key":"10.1016\/j.euroneuro.2015.05.007_bib5","doi-asserted-by":"crossref","first-page":"e27206","DOI":"10.1371\/journal.pone.0027206","article-title":"The influence of genetic and environmental factors among MDMA users in cognitive performance","volume":"6","author":"Cuy\u00e0s","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1365-2125.2000.00121.x","article-title":"Non-linear pharmacokinetics of MDMA (\u2018ecstasy\u2019) in humans","volume":"49","author":"de la Torre","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1749-6632.2000.tb05199.x","article-title":"Pharmacology of MDMA in humans","volume":"914","author":"de la Torre","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00007691-200404000-00009","article-title":"Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition","volume":"26","author":"de la Torre","year":"2004","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00228-005-0965-y","article-title":"MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers","volume":"61","author":"de la Torre","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/0269881107081545","article-title":"Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study","volume":"22","author":"de Sola Llopis","year":"2008","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib18","unstructured":"EMCDDA, 2014. European Drug Report 2014: Trends and Developments. Lisbon. Available from: \u3008http:\/\/www.emcdda.europa.eu\/publications\/edr\/trends-developments\/2014\u3009."},{"key":"10.1016\/j.euroneuro.2015.05.007_bib11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0022-3565(24)36982-4","article-title":"Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolism","volume":"283","author":"Farr\u00e9","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib12","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00213-004-1789-7","article-title":"Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics","volume":"173","author":"Farr\u00e9","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib13","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/jpet.107.129056","article-title":"Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics","volume":"323","author":"Farr\u00e9","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0892-0362(95)00013-H","article-title":"Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys","volume":"17","author":"Frederick","year":"1995","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejphar.2004.07.006","article-title":"A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response","volume":"500","author":"Green","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00213-008-1453-8","article-title":"MDMA: on the translation from rodent to human dosing","volume":"204","author":"Green","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/ajem.2003.50028","article-title":"Multiple toxicity from 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d)","volume":"21","author":"Greene","year":"2003","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib19","unstructured":"Haertzen, C.A., 1974. An overview of the Addiction Center Research Inventory: An Appendix and Manuals of Scales. DHEWS Pub. no.(ADM) 79, pp. 74\u201392."},{"key":"10.1016\/j.euroneuro.2015.05.007_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/bmj.3.5715.132","article-title":"Measurement of recovery from outpatient general anaesthesia with a simple ocular test","volume":"3","author":"Hannington-Kiff","year":"1970","journal-title":"Br Med J"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/jpet.300.1.236","article-title":"3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics","volume":"300","author":"Hern\u00e1ndez-L\u00f3pez","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib22","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/clpt.2011.78","article-title":"The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA (\u201cecstasy\u201d) in humans","volume":"90","author":"Hysek","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib23","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1124\/jpet.111.188425","article-title":"Effects of the \u03b12-adrenergic agonist clonidine on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine in healthy volunteers","volume":"340","author":"Hysek","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1017\/S1461145713001132","article-title":"Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination","volume":"17","author":"Hysek","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib25","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.npp.1300896","article-title":"Plasma drug concentrations and physiological measures in \u2018dance party\u2019 participants","volume":"31","author":"Irvine","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib26","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1007\/s00213-014-3528-z","article-title":"MDMA effects consistent across laboratories","volume":"231","author":"Kirkpatrick","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00213-006-0679-6","article-title":"Acute effects of nocturnal doses of MDMA on measures of impulsivity and psychomotor performance throughout the night","volume":"192","author":"Kuypers","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib28","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1177\/02698811080220081401","article-title":"Memory and mood during the night and in the morning after repeated evening doses of MDMA","volume":"22","author":"Kuypers","year":"2008","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0376-8716(94)90075-2","article-title":"Spanish version of the 49-item short form of the Addiction Research Center Inventory (ARCI)","volume":"35","author":"Lamas","year":"1994","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib30","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/hup.2234","article-title":"Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases","volume":"27","author":"Licht","year":"2012","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cpt1971122part1245","article-title":"Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man","volume":"12","author":"Martin","year":"1971","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1369-1600.2009.00180.x","article-title":"5-HTTLPR polymorphism, mood disordersand MDMA use in a 3-year follow-up study","volume":"15","author":"Mart\u00edn-Santos","year":"2010","journal-title":"Addict Biol"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-3565(24)34877-3","article-title":"Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans","volume":"290","author":"Mas","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib34","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0269881110378371","article-title":"The safety and efficacy of {\u00b1}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study","volume":"25","author":"Mithoefer","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib35","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/j.1360-0443.2011.03399.x","article-title":"Pill content, dose and resulting plasma concentrations of 3,4-methylendioxymethamphetamine (MDMA) in recreational \u2018ecstasy\u2019 users","volume":"106","author":"Morefield","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib36","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/0269881112464827","article-title":"A randomized, controlled pilot study of MDMA (\u00b1 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)","volume":"27","author":"Oehen","year":"2013","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.drugalcdep.2013.02.002","article-title":"Male and female ecstasy users: differences in patterns of use, sleep quality and mental health outcomes","volume":"132","author":"Ogeil","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib38","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/JCP.0b013e318184ff6e","article-title":"The consequences of 3,4-methylenedioxymethamphetamine induced CYP2D6 inhibition in humans","volume":"28","author":"O\u05f3Mathuna","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib39","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0028-3908(98)00029-X","article-title":"The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (\u2018ecstasy\u2019)","volume":"37","author":"O\u05f3Shea","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib40","doi-asserted-by":"crossref","first-page":"e47599","DOI":"10.1371\/journal.pone.0047599","article-title":"Clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d): the influence of gender and genetics (CYP2D6, COMT, 5-HTT)","volume":"7","author":"Pardo-Lozano","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/0269881105048900","article-title":"Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or ecstasy","volume":"19","author":"Parrott","year":"2005","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib42","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00213-009-1750-x","article-title":"Effects of repeated MDMA administration on the motivation for palatable food and extinction of operant responding in mice","volume":"208","author":"Plaza-Zabala","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib43","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00213-012-2894-7","article-title":"Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2h apart","volume":"225","author":"Peir\u00f3","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib44","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00002826-199108000-00007","article-title":"Clinical effects of daily methamphetamine administration","volume":"14","author":"P\u00e9rez-Reyes","year":"1991","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib45","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1037\/1064-1297.5.3.235","article-title":"Effects of abused drugs on psychomotor performance","volume":"5","author":"Pickworth","year":"1997","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib46","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/jat\/26.3.157","article-title":"Determination of MDMA and its metabolites in blood and urine by gas chromatography\u2013mass spectrometry and analysis of enantiomers by capillary electrophoresis","volume":"26","author":"Pizarro","year":"2002","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1369-1600.2011.00421.x","article-title":"Effects of repeated treatment with MDMA on working memory and behavioural flexibility in mice","volume":"18","author":"Vi\u00f1als","year":"2013","journal-title":"Addict Biol Mar"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib48","series-title":"The Measurement and Appraisal of Adult Intelligence","author":"Wechsler","year":"1958"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib49","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1177\/0269881106065907","article-title":"Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA","volume":"20","author":"Yang","year":"2006","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.euroneuro.2015.05.007_bib50","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/11584550-000000000-00000","article-title":"Sex differences in 3,4-methylenedioxymethamphetamine (MDMA; ecstasy)-induced cytochrome P450 2D6 inhibition in humans","volume":"50","author":"Yubero-Lahoz","year":"2011","journal-title":"Clin Pharmacokinet"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X15001637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X15001637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T07:48:30Z","timestamp":1748418510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X15001637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0924977X15001637"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2015.05.007","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 4h apart Human pharmacology of MDMA after repeated doses taken 4h apart","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2015.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}